文献

J-GLOBAL ID：202002268060864617   整理番号：20A1431255

本態性高血圧症患者におけるチアジド系利尿薬治療後の尿酸上昇に関連する遺伝的因子

Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension

著者 (39件)： Ohta Yuko (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Ohta Yuko (Department of General Internal Medicine, Kyushu Dental University, Fukuoka, Japan) ,  Kamide Kei (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Kamide Kei (Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Hanada Hironori (Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Morimoto Shigeto (Department of Geriatric Medicine, Kanazawa Medical University, Ishishikawa, Japan) ,  Nakahashi Takeshi (Department of Geriatric Medicine, Kanazawa Medical University, Ishishikawa, Japan) ,  Takiuchi Shin (Department of Cardiology, Higashi-Takarazuka Satoh Hospital, Hyogo, Japan) ,  Ishimitsu Toshihiko (Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Tochigi, Japan) ,  Tsuchihashi Takuya (Steel Memorial Yawata Hospital, Fukuoka, Japan) ,  Soma Masayoshi (Division of General Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Tomohiro Katsuya T. (Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Sugimoto Ken (Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Rakugi Hiromi (Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Oukura Takafumi (Department of Integrated Medicine and Informatics, University Graduate School of Medicine, Ehime, Japan) ,  Higaki Jitsuo (Department of Integrated Medicine and Informatics, University Graduate School of Medicine, Ehime, Japan) ,  Matsuura Hideo (Saiseikai Kure Hospital, Hiroshima, Japan) ,  Shinagawa Tatsuo (Japanese Red Cross Nagasaki Atomic Bomb Hospital, Nagasaki, Japan) ,  Miwa Yosikazu (Departments of Clinical Pharmacology, Kyushu University Graduate School of Medicine, Fukuoka, Japan) ,  Sasaguri Toshiyuki (Departments of Clinical Pharmacology, Kyushu University Graduate School of Medicine, Fukuoka, Japan) ,  Igase Michiya (Geriatric Medicine, Ehime University Graduate School of Medicine, Ehime, Japan) ,  Miki Tetsuro (Geriatric Medicine, Ehime University Graduate School of Medicine, Ehime, Japan) ,  Takeda Kazuo (Kyotokojohokenkai Hospital, Kyoto, Japan) ,  Higashiura Katsuhiro (Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Hokkaido, Japan) ,  Shimamoto Kazuaki (Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Hokkaido, Japan) ,  Katabuchi Ritsuko (National Fukuoka-Higashi Medical Center, Fukuoka, Japan) ,  Ueno Michio (National Fukuoka-Higashi Medical Center, Fukuoka, Japan) ,  Hosomi Naonaga (Department of Neurology, Hiroshima University Graduate School of Medicine, Hiroshima, Japan) ,  Kato Johji (Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan) ,  Komai Norio (Division of Nephrology, Department of Internal Medicine, Kawasaki Medical School, Okayama, Japan) ,  Kojima Shunichi (National Hospital Organization Shizuoka Medical Center, Shizuoka, Japan) ,  Sase Kazuhiro (Clinical Pharmacology, Juntendo University, Tokyo, Japan) ,  Iwashima Yoshio (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Yoshihara Fumiki (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Horio Takeshi (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Nakamura Satoko (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Nakahama Hajime (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Miyata Toshiyuki (Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan) ,  Kawano Yuhei (Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Osaka, Japan)
資料名： Hypertension Research  (Hypertension Research)
巻： 43  号： 3  ページ： 220-226  発行年： 2020年03月 
JST資料番号： Y0303A  ISSN： 0916-9636  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 本態性高血圧患者におけるチアジド系利尿薬(TD)による治療後...

シソーラス用語： ヒト ,...
準シソーラス用語： *チアジド系利尿薬 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1431255&from=J-GLOBAL&jstjournalNo=Y0303A") }}

著者キーワード (6件)： 高血圧 ,  腎機能 ,  尿酸 ,  チアジド様利尿薬 ,  血圧 ,  遺伝因子

分類 (3件)： 循環系疾患の薬物療法  (GJ05020M) ,  血管作用薬・降圧薬の臨床への応用  (GW07050U) ,  遺伝的変異  (EC01030Y)

物質索引 (4件)： アムロジピン ,  インダパミド ,  バルサルタン ,  尿酸

タイトルに関連する用語 (7件)： 本態性高血圧症 ,  患者 ,  チアジド系利尿薬 ,  治療 ,  尿酸 ,  遺伝 ,  因子